Overview

Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The purpose of this study is to assess the impact on daily life for children new to using a growth hormone injection device.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Hormones